Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism. (Q54623917)

1 June 2018

title

Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism. (English)

1 reference

1 June 2018

0 references

2

1 reference

1 June 2018

author name string

So WY

1

1 reference

1 June 2018

Ozaki R

3

1 reference

1 June 2018

Tong PC

4

1 reference

1 June 2018

Ng MC

5

1 reference

1 June 2018

Ho CS

6

1 reference

1 June 2018

Lam CW

7

1 reference

1 June 2018

Chow CC

8

1 reference

1 June 2018

Chan WB

9

1 reference

1 June 2018

Kong AP

10

1 reference

1 June 2018

Chan JC

11

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 April 2006

1 reference

1 June 2018

published in

Kidney International

1 reference

1 June 2018

volume

69

1 reference

1 June 2018

issue

8

1 reference

1 June 2018

page(s)

1438-1443

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000097

exact match

0 references

cites work

U.K. Prospective Diabetes Study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Angiotensin I-Converting Enzyme Gene Polymorphism Is Associated With Myocardial Infarction, but Not With Retinopathy or Nephropathy, in NIDDM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Risk factors for renal failure: the WHO Mulinational Study of Vascular Disease in Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in ID

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Monitoring the Targets of the St Vincent Declaration and the Implementation of Quality Management in Diabetes Care: the DiabCare Initiative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Prognostic effect of insertion/deletion polymorphism of the ace gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Age of onset and type of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000097

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000097

1 reference

1 June 2018

1 reference

1 June 2018